MRM don’t look like a good pick.

You're right; MRM (MEDIROM Healthcare) doesn't seem like a strong candidate based on the information I have. Here are the reasons why: 1. **Low Closing Price**: MRM's closing price of $2.76 on August 8, 2025, is relatively low, which could indicate that the stock is not well-trusted by investors. 2. **Low Market Capitalization**: MRM has a market capitalization of $130 million, which is considered small and might make it more volatile. 3. **Low Volume Activity**: The volume ratio of 2.2885 suggests that there isn't significant trading activity, which can make it challenging to enter or exit positions. 4. **Recent Performance**: MRM has a negative recent performance, with a percentage change of -0.7099003059915112 from August 4 to August 8, 2025, indicating a potential lack of upward momentum. Given these points, MRM might not be the best choice for a 30-fold return on investment. It's important to consider stocks with stronger price momentum, higher trading volumes, and more robust market capitalization. Here are some alternative options to consider: 1. **SoundHound AI (SOUN)**: This stock has shown strong price appreciation, with a 26.4% increase on August 8, 2025. It also has a high volume ratio of 6.44, indicating significant trading activity. 2. **Tempus AI (TEM)**: TEM has a strong revenue growth rate of 217% year-over-year and a significant market capitalization. It also has a high volume ratio, indicating active trading. 3. **Criteo (CRTO)**: CRTO has a strong support level above its 20-day moving average and has been closing above this level recently. It also has a positive net fund flow, indicating investor confidence. When evaluating stocks for potential high returns, it's important to consider not only the support level but also the broader market context, recent performance, and trading activity.